Literature DB >> 24833623

The natriuretic effect of angiotensin receptor blockers is not attributable to blood pressure reduction during the previous night, but to inhibition of tubular sodium reabsorption.

Toshiyuki Miura1, Shuichi Watanabe1, Maki Urushihara2, Hiroyuki Kobori2, Michio Fukuda3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24833623      PMCID： PMC4163113          DOI： 10.1177/1470320313518253

Source DB:  PubMed          Journal:  J Renin Angiotensin Aldosterone Syst        ISSN： 1470-3203            Impact factor:   1.636


× No keyword cloud information.
  14 in total

1.  Circadian rhythm of urinary potassium excretion during treatment with an angiotensin receptor blocker.

Authors:  Yoshiaki Ogiyama; Toshiyuki Miura; Shuichi Watanabe; Daisuke Fuwa; Tatsuya Tomonari; Keisuke Ota; Yoko Kato; Tadashi Ichikawa; Yuichi Shirasawa; Akinori Ito; Atsuhiro Yoshida; Michio Fukuda; Genjiro Kimura
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2013-02-06       Impact factor: 1.636

2.  Long-term regulation of ENaC expression in kidney by angiotensin II.

Authors:  Kathleen T Beutler; Shyama Masilamani; Sharon Turban; Jakob Nielsen; Heddwen L Brooks; Shana Ageloff; Robert A Fenton; Randall K Packer; Mark A Knepper
Journal:  Hypertension       Date:  2003-04-07       Impact factor: 10.190

3.  Endogenous production of angiotensin II modulates rat proximal tubule transport.

Authors:  A Quan; M Baum
Journal:  J Clin Invest       Date:  1996-06-15       Impact factor: 14.808

4.  Angiotensin II directly stimulates ENaC activity in the cortical collecting duct via AT(1) receptors.

Authors:  János Peti-Peterdi; David G Warnock; P Darwin Bell
Journal:  J Am Soc Nephrol       Date:  2002-05       Impact factor: 10.121

5.  Effect of luminal angiotensin II and ANP on early and late cortical distal tubule HCO3- reabsorption.

Authors:  M L Barreto-Chaves; M Mello-Aires
Journal:  Am J Physiol       Date:  1996-11

6.  Angiotensin II inhibits NaCl absorption in the rat medullary thick ascending limb.

Authors:  Nicolas Lerolle; Soline Bourgeois; Françoise Leviel; Gaëtan Lebrun; Michel Paillard; Pascal Houillier
Journal:  Am J Physiol Renal Physiol       Date:  2004-04-20

7.  Losartan reduces central and peripheral sympathetic nerve activity in a rat model of neurogenic hypertension.

Authors:  Shaohua Ye; Huiquin Zhong; Vu Ngoc Duong; Vito M Campese
Journal:  Hypertension       Date:  2002-06       Impact factor: 10.190

8.  Nocturnal blood pressure is elevated with natriuresis and proteinuria as renal function deteriorates in nephropathy.

Authors:  Michio Fukuda; Miwa Munemura; Takeshi Usami; Naoyuki Nakao; Oki Takeuchi; Yoshinobu Kamiya; Atsuhiro Yoshida; Genjiro Kimura
Journal:  Kidney Int       Date:  2004-02       Impact factor: 10.612

9.  Angiotensin II type 1 receptor blocker, olmesartan, restores nocturnal blood pressure decline by enhancing daytime natriuresis.

Authors:  Michio Fukuda; Tamaki Yamanaka; Masashi Mizuno; Masahiro Motokawa; Yuichi Shirasawa; Sota Miyagi; Takae Nishio; Atsuhiro Yoshida; Genjiro Kimura
Journal:  J Hypertens       Date:  2008-03       Impact factor: 4.844

10.  AT1 receptor mediated augmentation of intrarenal angiotensinogen in angiotensin II-dependent hypertension.

Authors:  Hiroyuki Kobori; Minolfa C Prieto-Carrasquero; Yuri Ozawa; L Gabriel Navar
Journal:  Hypertension       Date:  2004-03-22       Impact factor: 10.190
View more
  3 in total

1.  Sodium balance, circadian BP rhythm, heart rate variability, and intrarenal renin-angiotensin-aldosterone and dopaminergic systems in acute phase of ARB therapy.

Authors:  Yukako Isobe-Sasaki; Michio Fukuda; Yoshiaki Ogiyama; Ryo Sato; Toshiyuki Miura; Daisuke Fuwa; Masashi Mizuno; Tetsuhei Matsuoka; Hiroko Shibata; Hiroyuki Ito; Minamo Ono; Sumiko Abe-Dohmae; Ken Kiyono; Yoshiharu Yamamoto; Hiroyuki Kobori; Makoto Michikawa; Junichiro Hayano; Nobuyuki Ohte
Journal:  Physiol Rep       Date:  2017-06

Review 2.  Nephrotic Syndrome: Oedema Formation and Its Treatment With Diuretics.

Authors:  Sanjana Gupta; Ruth J Pepper; Neil Ashman; Stephen B Walsh
Journal:  Front Physiol       Date:  2019-01-15       Impact factor: 4.566

3.  Addition of hydrochlorothiazide to angiotensin receptor blocker therapy can achieve a lower sodium balance with no acceleration of intrarenal renin angiotensin system in patients with chronic kidney disease.

Authors:  Daisuke Fuwa; Michio Fukuda; Yoshiaki Ogiyama; Ryo Sato; Masashi Mizuno; Toshiyuki Miura; Sumiko Abe-Dohmae; Makoto Michikawa; Hiroyuki Kobori; Nobuyuki Ohte
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2016-06-09       Impact factor: 1.636
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.